Overview

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the effects of sequential multiple dose regimens of cariprazine on cardiac repolarization in patients with schizophrenia.
Phase:
Phase 1
Details
Lead Sponsor:
Forest Laboratories
Treatments:
Cariprazine
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Risperidone